scholarly journals COVID-19 associated with immune thrombocytopenia: a systematic review and meta-analysis

2022 ◽  
Author(s):  
Mohammed Ghannam Alharbi
Keyword(s):  
Systematic Review ◽  
Immune Thrombocytopenia ◽  
Meta Analysis

scholarly journals Comparison of up-front treatments for newly diagnosed immune thrombocytopenia -a systematic review and network meta-analysis

Haematologica ◽  
2017 ◽  
Vol 103 (1) ◽  
pp. 163-171 ◽  
Author(s):  
Yasuyuki Arai ◽  
Tomoyasu Jo ◽  
Hiroyuki Matsui ◽  
Tadakazu Kondo ◽  
Akifumi Takaori-Kondo
Keyword(s):  
Systematic Review ◽  
Immune Thrombocytopenia ◽  
Meta Analysis ◽  
Newly Diagnosed

scholarly journals The sensitivity and specificity of platelet autoantibody testing in immune thrombocytopenia: a systematic review and meta‐analysis of a diagnostic test

2019 ◽  
Vol 17 (5) ◽  
pp. 787-794 ◽  
Author(s):  
John R. Vrbensky ◽  
Joyce E. Moore ◽  
Donald M. Arnold ◽  
James W. Smith ◽  
John G. Kelton ◽  
...  
Keyword(s):  
Systematic Review ◽  
Diagnostic Test ◽  
Sensitivity And Specificity ◽  
Immune Thrombocytopenia ◽  
Meta Analysis

scholarly journals Treatment efficacy for adult persistent immune thrombocytopenia: a systematic review and network meta‐analysis

2019 ◽  
Vol 188 (3) ◽  
pp. 450-459 ◽  
Author(s):  
Teeraya Puavilai ◽  
Kunlawat Thadanipon ◽  
Sasivimol Rattanasiri ◽  
Atiporn Ingsathit ◽  
Mark McEvoy ◽  
...  
Keyword(s):  
Systematic Review ◽  
Treatment Efficacy ◽  
Immune Thrombocytopenia ◽  
Meta Analysis

scholarly journals Clinical and laboratory predictors of chronic immune thrombocytopenia in children: a systematic review and meta-analysis

Blood ◽  
2014 ◽  
Vol 124 (22) ◽  
pp. 3295-3307 ◽  
Author(s):  
Katja M. J. Heitink-Pollé ◽  
Joyce Nijsten ◽  
Chantal W. B. Boonacker ◽  
Masja de Haas ◽  
Marrie C. A. Bruin
Keyword(s):  
Risk Factors ◽  
Systematic Review ◽  
Platelet Count ◽  
Immune Thrombocytopenia ◽  
Meta Analysis ◽  
Chronic Itp ◽  
Insidious Onset ◽  
Key Points ◽  
Immunoglobulin Treatment ◽  
Chronic Immune Thrombocytopenia

Key Points Older age, insidious onset, no preceding infection, mild bleeding, and higher platelet count are the strongest risk factors for chronic ITP. Intravenous immunoglobulin treatment seems to protect against development of chronic ITP.

Sign in / Sign up

Export Citation Format

Share Document